Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States

American Heart Journal

Volumn 152, Issue 6, 2006, Pages 1035-1041

  Fang, Jing ^a   Mensah, George A ^a   Alderman, Michael H ^b   Croft, Janet B ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; UNITED STATES;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; SEX DISTRIBUTION; SHOCK, CARDIOGENIC; UNITED STATES;

EID: 33845222098     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.07.013     Document Type: Article

References (34)

1. Hochman J.S., Boland J., Sleeper L.A., et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation 91 (1995) 873-881
2. Antoniucci D., Valenti R., Santoro G.M., et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 31 (1998) 294-300
3. Berger P.B., Tuttle R.H., Holmes Jr. D.R., et al. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial. Circulation 99 (1999) 873-878
4. Goldberg R.J., Gore J.M., Alpert J.S., et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. New Engl J Med 325 (1991) 1117-1122
5. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. New Engl J Med 341 (1999) 625-634
6. Dens J., Dubois C., Ector H., et al. Survival of patients treated with intra-aortic balloon counterpulsation for cardiogenic shock in a tertiary centre: variables correlated with death. Eur J Emerg Med 10 (2003) 213-218
7. Doven O., Akkus M.N., Camsari A., et al. Impact of invasive strategy for the management of patients with cardiogenic shock after acute myocardial infarction. Coron Artery Dis 15 (2004) 361-366
8. Jacobs A.K., French J.K., Col J., et al. Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK trial registry. Should we emergently revascularize occluded coronaries for cardiogenic shock?. J Am Coll Cardiol 36 3 Suppl A (2000) 1091-1096
9. Goldberg R.J., Samad N.A., Yarzebski J., et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. New Engl J Med 340 (1999) 1162-1168
10. Gore J.M., Goldberg R.J., Spodick D.H., et al. A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest 92 (1987) 721-727
11. Fang J., and Alderman M.H. Revascularization among patients with acute myocardial infarction complicated by cardiogenic shock and impact of American College of Cardiology/American Heart Association guidelines. Am J Cardiol 94 (2004) 1281-1285
12. The role of primary angioplasty in patients presenting with acute myocardial infarction. American College of Emergency Physicians. Ann Emerg Med 35 (2000) 532-533
13. Ajani A.E., and Waksman R. Contemporary revascularization strategies in 2002. Drugs Today 38 (2002) 309-319
14. Barron H.V., Every N.R., Parsons L.S., et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 141 (2001) 933-939
15. Barry W.L., and Sarembock I.J. Cardiogenic shock: therapy and prevention. Clin Cardiol 21 (1998) 72-80
16. Babaev A., Frederick P.D., Pasta D.J., et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294 (2005) 448-454
17. Carnendran L., Abboud R., Sleeper L.A., et al. Trends in cardiogenic shock: report from the SHOCK study. The should we emergently revascularize occluded coronaries for cardiogenic shock?. Eur Heart J 22 (2001) 472-478
18. Dennison C.F., and Pokras R. Design and operation of the National Hospital Discharge Survey: 1988 redesign. Vital Health Stat 1 (2000)
19. Dennison C., and Pokras R. Design and operation of the National Hospital Discharge Survey: 1988 redesign. Vital Health Stat-Series 1: Programs and Collection Procedures (2000) 1-42
20. NCHS Definitions-Civilian Population. NCHS 2005. http://www.cdc.gov/nchs/datawh/nchsdefs/pop.htm#civ Available at: URL
21. Ryan T.J., Antman E.M., Brooks N.H., et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 34 (1999) 890-911
22. Edep M.E., and Brown D.L. Effect of early revascularization on mortality from cardiogenic shock complicating acute myocardial infarction in California. Am J Cardiol 85 (2000) 1185-1188
23. Califf R.M., and Bengtson J.R. Cardiogenic shock. New Engl J Med 330 (1994) 1724-1730
24. Ohman E.M. Troponin and other cardiac markers: role in management of acute coronary syndromes. Aust N Z J Med 29 (1999) 436-443
25. Wu A.H.B. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. Scand J Clin Lab Invest Suppl 59 (1999) 74-82
26. Goldberg R.J., Mooradd M., Gurwitz J.H., et al. Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction). Am J Cardiol 82 (1998) 259-264
27. Peterson E.D., Shaw L.J., and Califf R.M. Risk stratification after myocardial infarction. Ann Intern Med 126 (1997) 561-582
28. Hasdai D., Holmes Jr. D.R., Califf R.M., et al. Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global utilization of streptokinase and tissue-plasminogen activator for occluded coronary arteries. Am Heart J 138 (1999) 21-31
29. Fincke R., Hochman J.S., Lowe A.M., et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 44 (2004) 340-348
30. Dzavik V., Burton J.R., Kee C., et al. Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients. Can J Cardiol 14 (1998) 923-930
31. Goff Jr. D.C., Howard G., Wang C.H., et al. Trends in severity of hospitalized myocardial infarction: the atherosclerosis risk in communities (ARIC) study, 1987-1994. Am Heart J 139 (2000) 874-880
32. McGovern P.G., Pankow J.S., Shahar E., et al. Recent trends in acute coronary heart disease-mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. New Engl J Med 334 (1996) 884-890
33. Rosamond W.D., Chambless L.E., Folsom A.R., et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. New Engl J Med 339 (1998) 861-867
34. Spencer F.A., Lessard D., Gore J.M., et al. Declining length of hospital stay for acute myocardial infarction and postdischarge outcomes: a community-wide perspective. Arch Intern Med 164 (2004) 733-740